TERM ID="NYU_TERM_1" STRING="Current clinical practice" FREQUENCY=1 START=534 END=559 LEMMA="CURRENT CLINICAL PRACTICE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_2" STRING="Drug Administration" FREQUENCY=2 START=1660 END=1679 LEMMA="DRUG ADMINISTRATION" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_3" STRING="Drug Administration" FREQUENCY=2 START=2011 END=2030 LEMMA="DRUG ADMINISTRATION" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_4" STRING="Nonplatinum doublets" FREQUENCY=1 START=2880 END=2900 LEMMA="NONPLATINUM DOUBLET" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_5" STRING="PFI" FREQUENCY=6 START=803 END=806 LEMMA="PERIPHERAL FLOW INDEX" LEMMA_FREQUENCY=6
TERM ID="NYU_TERM_6" STRING="PFI" FREQUENCY=6 START=1125 END=1128 LEMMA="PERIPHERAL FLOW INDEX" LEMMA_FREQUENCY=6
TERM ID="NYU_TERM_7" STRING="PFI" FREQUENCY=6 START=1327 END=1330 LEMMA="PERIPHERAL FLOW INDEX" LEMMA_FREQUENCY=6
TERM ID="NYU_TERM_8" STRING="PFI" FREQUENCY=6 START=1606 END=1609 LEMMA="PERIPHERAL FLOW INDEX" LEMMA_FREQUENCY=6
TERM ID="NYU_TERM_9" STRING="PFI" FREQUENCY=6 START=1898 END=1901 LEMMA="PERIPHERAL FLOW INDEX" LEMMA_FREQUENCY=6
TERM ID="NYU_TERM_10" STRING="PFI" FREQUENCY=6 START=2256 END=2259 LEMMA="PERIPHERAL FLOW INDEX" LEMMA_FREQUENCY=6
TERM ID="NYU_TERM_11" STRING="adding antiangiogenesis" FREQUENCY=1 START=138 END=161 LEMMA="ADDING ANTIANGIOGENESI" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_12" STRING="angiogenesis inhibitors" FREQUENCY=1 START=2414 END=2437 LEMMA="ANGIOGENESIS INHIBITOR" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_13" STRING="antiangiogenesis agents" FREQUENCY=1 START=2976 END=2999 LEMMA="ANTIANGIOGENESIS AGENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_14" STRING="antiangiogenesis therapy" FREQUENCY=1 START=404 END=428 LEMMA="ANTIANGIOGENESIS THERAPY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_15" STRING="carboplatin" FREQUENCY=1 START=1768 END=1779 LEMMA="CARBOPLATIN" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_16" STRING="chemoresistant phenotypes" FREQUENCY=1 START=2672 END=2697 LEMMA="CHEMORESISTANT PHENOTYPE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_17" STRING="chemosensitive" FREQUENCY=1 START=2653 END=2667 LEMMA="CHEMOSENSITIVE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_18" STRING="chemotherapy-sensitive dichotomy" FREQUENCY=1 START=2526 END=2558 LEMMA="CHEMOTHERAPY-SENSITIVE DICHOTOMY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_19" STRING="clinical activity" FREQUENCY=2 START=1437 END=1454 LEMMA="CLINICAL ACTIVITY" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_20" STRING="clinical activity" FREQUENCY=2 START=2469 END=2486 LEMMA="CLINICAL ACTIVITY" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_21" STRING="clinical outcomes" FREQUENCY=1 START=1040 END=1057 LEMMA="CLINICAL OUTCOME" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_22" STRING="clinical studies" FREQUENCY=1 START=1207 END=1223 LEMMA="CLINICAL STUDY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_23" STRING="clinical trials" FREQUENCY=1 START=503 END=518 LEMMA="CLINICAL TRIAL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_24" STRING="clinicians" FREQUENCY=1 START=1547 END=1557 LEMMA="CLINICIAN" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_25" STRING="combinations" FREQUENCY=2 START=2825 END=2837 LEMMA="COMBINATION" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_26" STRING="combinations" FREQUENCY=2 START=3009 END=3021 LEMMA="COMBINATION" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_27" STRING="cytotoxic agents" FREQUENCY=1 START=1403 END=1419 LEMMA="CYTOTOXIC AGENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_28" STRING="drug labeling" FREQUENCY=1 START=1696 END=1709 LEMMA="DRUG LABELING" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_29" STRING="emerging data" FREQUENCY=1 START=387 END=400 LEMMA="EMERGING DATA" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_30" STRING="epithelial ovarian cancer" FREQUENCY=1 START=219 END=244 LEMMA="EPITHELIAL OVARIAN CANCER" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_31" STRING="gemcitabine" FREQUENCY=1 START=1752 END=1763 LEMMA="GEMCITABINE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_32" STRING="liposomal doxorubicin" FREQUENCY=1 START=2127 END=2148 LEMMA="LIPOSOMAL DOXORUBICIN" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_33" STRING="nonplatinum agent" FREQUENCY=1 START=970 END=987 LEMMA="NONPLATINUM AGENT" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_34" STRING="nonplatinum agents" FREQUENCY=1 START=2802 END=2820 LEMMA="NONPLATINUM AGENT" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_35" STRING="nonplatinum chemotherapeutic agents" FREQUENCY=1 START=1253 END=1288 LEMMA="NONPLATINUM CHEMOTHERAPEUTIC AGENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_36" STRING="nonplatinum combinations" FREQUENCY=1 START=351 END=375 LEMMA="NONPLATINUM COMBINATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_37" STRING="nonplatinum doublet" FREQUENCY=1 START=2097 END=2116 LEMMA="NONPLATINUM DOUBLET" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_38" STRING="nonplatinum drugs" FREQUENCY=1 START=1376 END=1393 LEMMA="NONPLATINUM DRUG" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_39" STRING="objective" FREQUENCY=1 START=262 END=271 LEMMA="OBJECTIVE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_40" STRING="optimal treatment" FREQUENCY=1 START=176 END=193 LEMMA="OPTIMAL TREATMENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_41" STRING="ovarian cancer" FREQUENCY=2 START=645 END=659 LEMMA="OVARIAN CANCER" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_42" STRING="ovarian cancer" FREQUENCY=2 START=2352 END=2366 LEMMA="OVARIAN CANCER" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_43" STRING="pegylated liposomal doxorubicin" FREQUENCY=1 START=1942 END=1973 LEMMA="PEGYLATED LIPOSOMAL DOXORUBICIN" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_44" STRING="platinum agent" FREQUENCY=1 START=857 END=871 LEMMA="PLATINUM AGENT" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_45" STRING="platinum agents" FREQUENCY=1 START=1507 END=1522 LEMMA="PLATINUM AGENT" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_46" STRING="platinum combinations" FREQUENCY=1 START=2212 END=2233 LEMMA="PLATINUM COMBINATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_47" STRING="platinum compound exposure" FREQUENCY=1 START=751 END=777 LEMMA="PLATINUM COMPOUND EXPOSURE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_48" STRING="platinum-free exposure" FREQUENCY=1 START=685 END=707 LEMMA="PLATINUM-FREE EXPOSURE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_49" STRING="platinum-free interval" FREQUENCY=1 START=779 END=801 LEMMA="PLATINUM-FREE INTERVAL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_50" STRING="platinum-sensitive patients" FREQUENCY=1 START=2051 END=2078 LEMMA="PLATINUM-SENSITIVE PATIENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_51" STRING="platinum-sensitive recurrent disease" FREQUENCY=1 START=2927 END=2963 LEMMA="PLATINUM-SENSITIVE RECURRENT DISEASE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_52" STRING="platinum-sensitive recurrent ovarian cancer" FREQUENCY=2 START=42 END=85 LEMMA="PLATINUM-SENSITIVE RECURRENT OVARIAN CANCER" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_53" STRING="platinum-sensitive recurrent ovarian cancer" FREQUENCY=2 START=1814 END=1857 LEMMA="PLATINUM-SENSITIVE RECURRENT OVARIAN CANCER" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_54" STRING="prolific developmental therapeutics arena" FREQUENCY=1 START=2307 END=2348 LEMMA="PROLIFIC DEVELOPMENTAL THERAPEUTICS ARENA" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_55" STRING="targeted therapy" FREQUENCY=1 START=2383 END=2399 LEMMA="TARGETED THERAPY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_56" STRING="term platinum" FREQUENCY=1 START=2703 END=2716 LEMMA="TERM PLATINUM" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_57" STRING="topotecan" FREQUENCY=1 START=1928 END=1937 LEMMA="TOPOTECAN" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_58" STRING="trabectedin" FREQUENCY=1 START=2153 END=2164 LEMMA="TRABECTEDIN" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_59" STRING="treatment algorithm" FREQUENCY=1 START=611 END=630 LEMMA="TREATMENT ALGORITHM" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_60" STRING="unknown" FREQUENCY=1 START=2454 END=2461 LEMMA="UNKNOWN" LEMMA_FREQUENCY=1
